Biotechnology Assets, S.A. (BME:BST)

Market Cap	17.01M -27.7%
Revenue (ttm)	3.43M -4.9%
Net Income	-1.92M
EPS	n/a
Shares Out	74.29M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	38,004
Open	0.2230
Previous Close	0.2290
Day's Range	0.2140 - 0.2240
52-Week Range	0.1760 - 0.4750
Beta	1.82
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 21, 2026

About Biotechnology Assets

Biotechnology Assets, S.A. develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industries in Spain and internationally. It offers SPLITTERA, a solution for site-specific conjugation of proteins; Click Car for Split-CARs universal connectors; VACC-ZERA, a tool to generate recombinant proteins in microparticles; and CLICK’N CUT for tag-less protein purification. The company is based in Cádiz, Spain.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1954
• Employees: 26
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: BST

Financial Performance

In 2025, Biotechnology Assets's revenue was 3.43 million, a decrease of -4.88% compared to the previous year's 3.61 million. Losses were -1.92 million, -34.32% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 7, 2026

Data Sources Report a data error